Perspective Therapeutics ...

AMEX: CATX · Real-Time Price · USD
3.69
-0.21 (-5.38%)
At close: Aug 15, 2025, 12:20 PM

Perspective Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Jun 30, 2022
Net Income
-79.28M -46.51M -14.67M -7.27M
Depreciation & Amortization
2.31M 946K 344K 248K
Stock-Based Compensation
5.39M 3.74M 1.34M 1.09M
Other Working Capital
n/a 779K n/a 182K
Other Non-Cash Items
55.39M 5.27M 472K 77K
Deferred Income Tax
-2.1M -2.65M -1.68M n/a
Change in Working Capital
n/a 2.3M 338K -1.85M
Operating Cash Flow
-18.29M -36.91M -12.17M -7.71M
Capital Expenditures
-54.41M -1.07M -302K -266K
Cash Acquisitions
n/a 2.7M n/a n/a
Purchase of Investments
-243.51M n/a n/a n/a
Sales Maturities Of Investments
n/a 22.76M n/a n/a
Other Investing Acitivies
78.99M -18K -57.38M -18K
Investing Cash Flow
-218.93M 24.37M -57.68M -284K
Debt Repayment
n/a -68K n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
289.38M 489K 56K n/a
Financial Cash Flow
289.38M 785K 56K 56K
Net Cash Flow
52.16M -46.65M 182K -7.94M
Free Cash Flow
-72.71M -37.98M -12.47M -7.98M